Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.

about

Early Biologic Treatment in Pediatric Crohn's Disease: Catching the Therapeutic Window of Opportunity in Early Disease by Treat-to-Target.The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn's Disease.

P2860

Q48518781-A4CC1B7D-17C6-46CA-B233-C2774EB96E22 Q55007762-5E14C1CD-44B1-4E6C-B9EC-E8F159C7DDE9

P2860

Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.

Item

http://www.wikidata.org/entity/Q49339951

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@en

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@nl

type

Item

label

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@en

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@nl

prefLabel

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@en

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@nl

P1476

Early Infliximab Yields Superi ...... tric Crohn's Disease Patients.

@en

P2093

Ben Kang

http://www.w3.org/2001/XMLSchema#string

Hae Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Insuk Sohn

http://www.w3.org/2001/XMLSchema#string

Jaeyoung Choi

http://www.w3.org/2001/XMLSchema#string

Min-Ji Kim

http://www.w3.org/2001/XMLSchema#string

Yon Ho Choe

http://www.w3.org/2001/XMLSchema#string

P2860

European evidence based consensus on the diagnosis and management of Crohn's disease: special situations

Growth and clinical course of children with Crohn's disease.

Fundamental mechanisms of growth failure in inflammatory bowel disease.

Delayed puberty associated with inflammatory bowel disease.

Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

Pediatric inflammatory bowel diseases and the risk of lymphoma: should we revise our treatment strategies?

A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease.

ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents.

Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.

Infliximab "Top-Down" Strategy is Superior to "Step-Up" in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease.

P304

255-262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5009/GNL17290

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29298460

http://www.w3.org/2001/XMLSchema#string

P932

5945256

http://www.w3.org/2001/XMLSchema#string

Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.

about

P2860

P2860

Early Infliximab Yields Superior Long-Term Effects on Linear Growth in Pediatric Crohn's Disease Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932